PT914340E - Analogos de hgh-rh(1-29)nh2 possuindo actividade antagonista - Google Patents
Analogos de hgh-rh(1-29)nh2 possuindo actividade antagonistaInfo
- Publication number
- PT914340E PT914340E PT97926399T PT97926399T PT914340E PT 914340 E PT914340 E PT 914340E PT 97926399 T PT97926399 T PT 97926399T PT 97926399 T PT97926399 T PT 97926399T PT 914340 E PT914340 E PT 914340E
- Authority
- PT
- Portugal
- Prior art keywords
- ala
- abu
- leu
- arg
- cit
- Prior art date
Links
- 239000005557 antagonist Substances 0.000 title 1
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 abstract 6
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical group OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 abstract 4
- KDXKERNSBIXSRK-RXMQYKEDSA-N D-lysine Chemical compound NCCCC[C@@H](N)C(O)=O KDXKERNSBIXSRK-RXMQYKEDSA-N 0.000 abstract 4
- -1 R3 is Asp Chemical compound 0.000 abstract 4
- AHLPHDHHMVZTML-SCSAIBSYSA-N D-Ornithine Chemical compound NCCC[C@@H](N)C(O)=O AHLPHDHHMVZTML-SCSAIBSYSA-N 0.000 abstract 3
- QNAYBMKLOCPYGJ-UWTATZPHSA-N D-alanine Chemical compound C[C@@H](N)C(O)=O QNAYBMKLOCPYGJ-UWTATZPHSA-N 0.000 abstract 3
- ODKSFYDXXFIFQN-SCSAIBSYSA-N D-arginine Chemical group OC(=O)[C@H](N)CCCNC(N)=N ODKSFYDXXFIFQN-SCSAIBSYSA-N 0.000 abstract 3
- JCXJVPUVTGWSNB-UHFFFAOYSA-N Nitrogen dioxide Chemical compound O=[N]=O JCXJVPUVTGWSNB-UHFFFAOYSA-N 0.000 abstract 3
- 125000003295 alanine group Chemical group N[C@@H](C)C(=O)* 0.000 abstract 3
- DCXYFEDJOCDNAF-UWTATZPHSA-N D-Asparagine Chemical compound OC(=O)[C@H](N)CC(N)=O DCXYFEDJOCDNAF-UWTATZPHSA-N 0.000 abstract 2
- CKLJMWTZIZZHCS-UHFFFAOYSA-N D-OH-Asp Natural products OC(=O)C(N)CC(O)=O CKLJMWTZIZZHCS-UHFFFAOYSA-N 0.000 abstract 2
- CKLJMWTZIZZHCS-UWTATZPHSA-N D-aspartic acid Chemical compound OC(=O)[C@H](N)CC(O)=O CKLJMWTZIZZHCS-UWTATZPHSA-N 0.000 abstract 2
- ZDXPYRJPNDTMRX-GSVOUGTGSA-N D-glutamine Chemical compound OC(=O)[C@H](N)CCC(N)=O ZDXPYRJPNDTMRX-GSVOUGTGSA-N 0.000 abstract 2
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 abstract 2
- AYFVYJQAPQTCCC-STHAYSLISA-N D-threonine Chemical compound C[C@H](O)[C@@H](N)C(O)=O AYFVYJQAPQTCCC-STHAYSLISA-N 0.000 abstract 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 abstract 2
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical group C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 2
- BAVYZALUXZFZLV-UHFFFAOYSA-N Methylamine Chemical compound NC BAVYZALUXZFZLV-UHFFFAOYSA-N 0.000 abstract 2
- 125000002252 acyl group Chemical group 0.000 abstract 2
- QWCKQJZIFLGMSD-UHFFFAOYSA-N alpha-aminobutyric acid Chemical compound CCC(N)C(O)=O QWCKQJZIFLGMSD-UHFFFAOYSA-N 0.000 abstract 2
- 125000003118 aryl group Chemical group 0.000 abstract 2
- 125000002038 D-arginyl group Chemical group N[C@@H](C(=O)*)CCCNC(=N)N 0.000 abstract 1
- WHUUTDBJXJRKMK-GSVOUGTGSA-N D-glutamic acid Chemical compound OC(=O)[C@H](N)CCC(O)=O WHUUTDBJXJRKMK-GSVOUGTGSA-N 0.000 abstract 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical group OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- ULEBESPCVWBNIF-BYPYZUCNSA-N L-arginine amide Chemical compound NC(=O)[C@@H](N)CCCNC(N)=N ULEBESPCVWBNIF-BYPYZUCNSA-N 0.000 abstract 1
- 125000002059 L-arginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C([H])([H])C([H])([H])N([H])C(=N[H])N([H])[H] 0.000 abstract 1
- 125000000010 L-asparaginyl group Chemical group O=C([*])[C@](N([H])[H])([H])C([H])([H])C(=O)N([H])[H] 0.000 abstract 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical group OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 abstract 1
- LRQKBLKVPFOOQJ-YFKPBYRVSA-N L-norleucine Chemical compound CCCC[C@H]([NH3+])C([O-])=O LRQKBLKVPFOOQJ-YFKPBYRVSA-N 0.000 abstract 1
- 125000000534 N(2)-L-lysino group Chemical group [H]OC(=O)[C@@]([H])(N([H])[*])C([H])([H])C([H])([H])C(C([H])([H])N([H])[H])([H])[H] 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Chemical compound CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 108010047254 alanyl-4-fluorophenylalanyl-arginyl-cyclohexylalanyl-citrulline-tyrosinamide Proteins 0.000 abstract 1
- MDFFNEOEWAXZRQ-UHFFFAOYSA-N aminyl Chemical compound [NH2] MDFFNEOEWAXZRQ-UHFFFAOYSA-N 0.000 abstract 1
- FXHCFPUEIDRTMR-UHFFFAOYSA-N hydron;1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid;chloride Chemical compound Cl.C1=CC=C2CNC(C(=O)O)CC2=C1 FXHCFPUEIDRTMR-UHFFFAOYSA-N 0.000 abstract 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/60—Growth-hormone releasing factors (GH-RF) (Somatoliberin)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/642,472 US5942489A (en) | 1996-05-03 | 1996-05-03 | HGH-RH(1-29)NH2 analogues having antagonistic activity |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT914340E true PT914340E (pt) | 2003-11-28 |
Family
ID=24576702
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT97926399T PT914340E (pt) | 1996-05-03 | 1997-05-02 | Analogos de hgh-rh(1-29)nh2 possuindo actividade antagonista |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US5942489A (pt) |
| EP (1) | EP0914340B1 (pt) |
| JP (1) | JP2001501585A (pt) |
| AT (1) | ATE244731T1 (pt) |
| AU (1) | AU3117297A (pt) |
| CA (1) | CA2253663C (pt) |
| DE (1) | DE69723448T2 (pt) |
| DK (1) | DK0914340T3 (pt) |
| ES (1) | ES2200178T3 (pt) |
| PT (1) | PT914340E (pt) |
| WO (1) | WO1997042223A1 (pt) |
| ZA (1) | ZA973793B (pt) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6057422A (en) * | 1998-11-25 | 2000-05-02 | The Administrators Of The Tulane Educational Fund | Antagonistic analogs of GH-RH inhibiting IGF-I and -II |
| US20040121407A1 (en) * | 2002-09-06 | 2004-06-24 | Elixir Pharmaceuticals, Inc. | Regulation of the growth hormone/IGF-1 axis |
| TW200517400A (en) * | 2003-08-05 | 2005-06-01 | Univ Tulane | Antagonistic analogs of GH-RH (2003) |
| WO2005090388A1 (en) | 2004-03-19 | 2005-09-29 | The University Of Queensland | Alpha helical mimics, their uses and methods for their production |
| MX2010010642A (es) * | 2008-03-28 | 2011-03-29 | The Univ Of Miami | Nuevos analogos antagonistas, sustituidos, n- y c- terminales, de hormona liberadora de hormona de crecimiento (gh-rh). |
| US8691942B2 (en) | 2008-03-28 | 2014-04-08 | University Of Miami | N- and C- terminal substituted antagonistic analogs of GH-RH |
| JP5799397B2 (ja) | 2008-06-12 | 2015-10-28 | イプセン・バイオイノベーション・リミテッドＩｐｓｅｎ Ｂｉｏｉｎｎｏｖａｔｉｏｎ Ｌｉｍｉｔｅｄ | 癌の抑制 |
| CA2727082C (en) | 2008-06-12 | 2019-02-26 | Syntaxin Limited | Fusion proteins for use in suppression of acromegaly |
| US8796216B2 (en) | 2008-06-12 | 2014-08-05 | Syntaxin Limited | Suppression of neuroendocrine diseases |
| GB0820970D0 (en) | 2008-11-17 | 2008-12-24 | Syntaxin Ltd | Suppression of cancer |
| US20100316639A1 (en) | 2009-06-16 | 2010-12-16 | Genentech, Inc. | Biomarkers for igf-1r inhibitor therapy |
| US9079974B2 (en) * | 2011-12-21 | 2015-07-14 | The University Of Miami | GH-RH analogs with potent agonistic effects |
| US9855312B2 (en) | 2012-12-21 | 2018-01-02 | University Of Miami | GHRH agonists for the treatment of ischemic disorders |
| EP2935317B1 (en) | 2012-12-21 | 2019-03-27 | University of Miami | Ghrh agonists for islet cell transplantation and function and the treatment of diabetes |
| US9119832B2 (en) | 2014-02-05 | 2015-09-01 | The Regents Of The University Of California | Methods of treating mild brain injury |
| EP3218395B1 (en) | 2014-11-12 | 2022-01-05 | The United States of America, as represented by The Secretary, Department of Health and Human Services | Treatment of hormonal disorders of growth |
| US20170121385A1 (en) | 2015-10-28 | 2017-05-04 | Oxeia Biopharmaceuticals, Inc. | Methods of treating neurodegenerative conditions |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4377515A (en) * | 1979-10-01 | 1983-03-22 | Merck & Co., Inc. | Long lasting agonists and antagonists of LH-RH |
| US4493934A (en) * | 1979-10-01 | 1985-01-15 | Merck & Co., Inc. | 2(3-Amino-2-oxopyrrolidin-1-yl) acetic acid and n-acylated derivatives thereof |
| US5043322A (en) * | 1988-07-22 | 1991-08-27 | The Salk Institute For Biological Studies | Cyclic GRF analogs |
| US5084442A (en) * | 1988-09-06 | 1992-01-28 | Hoffmann-La Roche Inc. | Cyclic growth hormone releasing factor analogs and method for the manufacture thereof |
| JPH06502618A (ja) * | 1990-05-04 | 1994-03-24 | ジ・アドミニストレイターズ・オブ・ザ・テュレイン・エデュケイショナル・ファンド | 新規な合成ｇｒｆ類似物 |
| EP0673387B1 (en) * | 1992-12-11 | 1999-09-22 | University Of Florida | Materials and methods for control of pests |
| US5550212A (en) * | 1993-12-17 | 1996-08-27 | The Administrators Of The Tulane Educational Fund | Analogues of hGH-RH(1-29)NH2 having antagonistic activity |
| US5516759A (en) * | 1994-12-08 | 1996-05-14 | Tap Holdings Inc. | LHRH antagonists having lactam groups at the N-terminus |
| DE19514567A1 (de) * | 1995-04-20 | 1996-10-24 | Merck Patent Gmbh | Benzofurane |
-
1996
- 1996-05-03 US US08/642,472 patent/US5942489A/en not_active Expired - Fee Related
-
1997
- 1997-05-02 WO PCT/US1997/007452 patent/WO1997042223A1/en active IP Right Grant
- 1997-05-02 DK DK97926399T patent/DK0914340T3/da active
- 1997-05-02 DE DE69723448T patent/DE69723448T2/de not_active Expired - Fee Related
- 1997-05-02 PT PT97926399T patent/PT914340E/pt unknown
- 1997-05-02 CA CA002253663A patent/CA2253663C/en not_active Expired - Fee Related
- 1997-05-02 ES ES97926399T patent/ES2200178T3/es not_active Expired - Lifetime
- 1997-05-02 ZA ZA9703793A patent/ZA973793B/xx unknown
- 1997-05-02 EP EP97926399A patent/EP0914340B1/en not_active Expired - Lifetime
- 1997-05-02 JP JP09540054A patent/JP2001501585A/ja not_active Ceased
- 1997-05-02 AU AU31172/97A patent/AU3117297A/en not_active Abandoned
- 1997-05-02 AT AT97926399T patent/ATE244731T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2200178T3 (es) | 2004-03-01 |
| DE69723448T2 (de) | 2004-05-19 |
| EP0914340B1 (en) | 2003-07-09 |
| EP0914340A1 (en) | 1999-05-12 |
| AU3117297A (en) | 1997-11-26 |
| DE69723448D1 (de) | 2003-08-14 |
| CA2253663A1 (en) | 1997-11-13 |
| ATE244731T1 (de) | 2003-07-15 |
| WO1997042223A1 (en) | 1997-11-13 |
| JP2001501585A (ja) | 2001-02-06 |
| DK0914340T3 (da) | 2003-10-27 |
| ZA973793B (en) | 1997-11-19 |
| US5942489A (en) | 1999-08-24 |
| CA2253663C (en) | 2002-07-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT914340E (pt) | Analogos de hgh-rh(1-29)nh2 possuindo actividade antagonista | |
| US6103870A (en) | CS-1 peptidomimetic, compositions and methods of using the same | |
| KR850001230A (ko) | 옥타펩티드 바조프레신 길항물질의 제조방법 | |
| CO5180565A1 (es) | Analogos antagonistas de gh-rh que inhiben igf-i y ii | |
| FI82254C (fi) | Foerfarande foer framstaellning av nya, terapeutiskt anvaendbara peptider och salter daerav. | |
| KR930701483A (ko) | Grf (쥐이알에프) 유사체 xi | |
| GR68039B (pt) | ||
| Dutta et al. | Potent cyclic monomeric and dimeric peptide inhibitors of VLA‐4 (α4β1 integrin)‐mediated cell adhesion based on the Ile‐Leu‐Asp‐Val tetrapeptide | |
| ES2152380T3 (es) | Analogos de hgh-rh(1-29)nh2 con actividad antagonista. | |
| AU707245B2 (en) | Novel MU opioid receptor ligands: agonists and antagonists | |
| IE800743L (en) | Peptides having thymopoietin-like activity | |
| IL72789A (en) | Basic hexa and heptapeptide vasopressin antagonists and their preparation | |
| ES8707740A1 (es) | Un procedimiento para preparar octapeptidos ciclicos | |
| EP0273645A3 (en) | Novel derivatives of arginine vasopressin antagonists | |
| HUT61033A (en) | Process for producing intermediates of lh-rh-antagonist peptides | |
| TH2820B (th) | เพพไทด์สังเคราะห์ที่แสดงฤทธิ์ปลดปล่อยฮอร์โมนช่วยการเติบโตของพิทูอิทารี |